Skip to main content

Table 2 Association between prescription of lansoprazole and risk of type 2 diabetes mellitus (T2DM)

From: Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study

Variable

No. of subjects

No. of T2DM cases

Crude HR (95% CI)

Adjusted HR (95% CI)

Othe PPIs

3336

845

1.00

1.00

Lansoprazole

1668

235

0.69 (0.59–0.80)

0.65 (0.56–0.76)

  1. Hazard ratios were adjusted for age, sex, index date, comorbidities, including heart failure, malignant neoplasms, cardiovascular disease, hypertension, hyperlipidemia, chronic liver disease, and chronic kidney disease as well as use of concomitant medications, including thiazide, beta blocking agents, statins, and corticosteroids
  2. T2DM type 2 diabetes mellitus, HR hazard ratio, CI confidence interval, PPI Proton pump inhibitor